Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Alimentary Pharmacology & Therapeutics
|
October 9, 2019
Letter: tofacitinib use for biologic-refractory paediatric inflammatory bowel disease
Michael T Dolinger, Priya Rolfes, Becky L Phan, et al.
The AAPS Journal
|
October 15, 2016
Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients
Marla C Dubinsky, Becky L Phan, Namita Singh, et al.
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|
August 1, 2019
Coping Among Parents of Teens With Inflammatory Bowel Disease
Katrine Carlsen, Becky L Phan, Nanci Pittman, et al.
The AAPS Journal
|
June 16, 2018
Dashboards for Therapeutic Monoclonal Antibodies: Learning and Confirming
Diane R Mould, Richard N Upton, Jessica Wojciechowski, et al.
Journal of Clinical Gastroenterology
|
May 27, 2020
Use of Small Bowel Ultrasound to Predict Response to Infliximab Induction in Pediatric Crohn's Disease
Michael T Dolinger, Jungwhan J Choi, Becky L Phan, et al.
Inflammatory Bowel Diseases
|
January 3, 2022
Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity
Marla C Dubinsky, Michelle L Mendiolaza, Becky L Phan, et al.
Inflammatory Bowel Diseases
|
June 6, 2018
Proactively Optimized Infliximab Monotherapy Is as Effective as Combination Therapy in IBD
Sara Lega, Becky L Phan, Casey J Rosenthal, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 7, 2019
Real World Experience With Ustekinumab in Children and Young Adults at a Tertiary Care Pediatric Inflammatory Bowel Disease Center
Judy R Dayan, Michael Dolinger, Keith Benkov, et al.
Inflammatory Bowel Diseases
|
August 20, 2016
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
Namita Singh, Shervin Rabizadeh, Jacqueline Jossen, et al.
Journal of Crohn'S & Colitis
|
May 16, 2019
Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease
Ryan C Ungaro, Andres Yarur, Jacqueline Jossen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Alimentary Pharmacology & Therapeutics
|
October 9, 2019
Letter: tofacitinib use for biologic-refractory paediatric inflammatory bowel disease
Michael T Dolinger, Priya Rolfes, Becky L Phan, et al.
The AAPS Journal
|
October 15, 2016
Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients
Marla C Dubinsky, Becky L Phan, Namita Singh, et al.
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|
August 1, 2019
Coping Among Parents of Teens With Inflammatory Bowel Disease
Katrine Carlsen, Becky L Phan, Nanci Pittman, et al.
The AAPS Journal
|
June 16, 2018
Dashboards for Therapeutic Monoclonal Antibodies: Learning and Confirming
Diane R Mould, Richard N Upton, Jessica Wojciechowski, et al.
Journal of Clinical Gastroenterology
|
May 27, 2020
Use of Small Bowel Ultrasound to Predict Response to Infliximab Induction in Pediatric Crohn's Disease
Michael T Dolinger, Jungwhan J Choi, Becky L Phan, et al.
Inflammatory Bowel Diseases
|
January 3, 2022
Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity
Marla C Dubinsky, Michelle L Mendiolaza, Becky L Phan, et al.
Inflammatory Bowel Diseases
|
June 6, 2018
Proactively Optimized Infliximab Monotherapy Is as Effective as Combination Therapy in IBD
Sara Lega, Becky L Phan, Casey J Rosenthal, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 7, 2019
Real World Experience With Ustekinumab in Children and Young Adults at a Tertiary Care Pediatric Inflammatory Bowel Disease Center
Judy R Dayan, Michael Dolinger, Keith Benkov, et al.
Inflammatory Bowel Diseases
|
August 20, 2016
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
Namita Singh, Shervin Rabizadeh, Jacqueline Jossen, et al.
Journal of Crohn'S & Colitis
|
May 16, 2019
Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease
Ryan C Ungaro, Andres Yarur, Jacqueline Jossen, et al.
Page
of 1